Notification about the intention to submit a non-competitive mandatory tender offer


Kaunas, Lithuania, 2011-08-19 11:51 CEST (GLOBE NEWSWIRE) -- On 19 August 2011 SANITAS AB received a notification that Valeant Pharmaceuticals International, Inc., a company established according to laws of the Canada, with its address registered at 7150 Mississauga Road, Mississauga, Ontario, Canada L5N 8M5 (hereinafter – Valeant), pursuant to its Board’s decision intend to submit a non-competitive mandatory tender offer to buy up the remaining 2,480,895 (two million four hundred eighty thousand eight hundred ninety five) ordinary registered shares of SANITAS AB (legal form: public limited liability company, legal entity code 134136296, registered at Veiverių st. 134B, Kaunas, the Republic of Lithuania, data about the company are collected and kept in the Register of Legal Persons of the Republic of Lithuania) with the par value of LTL 1 (one litas) each, constituting 7.98% (seven and ninety eight hundredths percent) of shares and votes carried by them at the general meeting of shareholders of SANITAS AB.
Valeant acquired more than 1/3 (one third) of shares of SANITAS AB on 19 of August, 2011 after the closing of the transaction of acquisition of shares of the company according to Share Sale and Purchase Agreement of 23 May 2011. Valeant owns 28,625,025 (twenty eight million six hundred twenty five thousand twenty five) ordinary registered shares of SANITAS AB with the par value of LTL 1 (one litas) each, constituting 92.02% (ninety two and two hundredths percent) of shares and votes carried by them at the general meeting of shareholders of SANITAS AB.
Intended way of settlement for the securities to be bought up is in cash. The intended price for the company’s shares subject to the offer: EUR 10.06 (the equivalent in litas is LTL 34.74) per share. The intended period of the offer: 14 calendar days. 

This notification is also available on AB Sanitas’ website: www.sanitasgroup.com

A person authorized to provide additional information: Mr. Saulius Jurgelenas, Chief Executive Officer of SANITAS AB phone number +370 686 67779.

         Lawyer
         Dovilė Morkytė
         +370 615 15163